BOLT icon

Bolt Biotherapeutics
BOLT

Overview Fund Activity

44 hedge funds and large institutions have $26.8M invested in Bolt Biotherapeutics in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 13 closing their positions.

Holders
44
Holders Change
-12
Holders Change %
-21.43%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
14
Reduced
12
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NM
1
Newtyn Management
New York
$1.5M
2
Goldman Sachs
2
Goldman Sachs
New York
$368K
3
TCM
3
Tang Capital Management
California
$520K
4
Millennium Management
4
Millennium Management
New York
$316K
5
BCM
5
Bridgeway Capital Management
Texas
$244K

Top Sellers

1
NHAS
1
Novo Holdings A/S
Denmark
$0
2
SCM
2
Suvretta Capital Management
New York
$0
3
RCM
3
RA Capital Management
Massachusetts
$0
4
BlackRock
4
BlackRock
New York
$355K
5
CCM
5
CAAS Capital Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Qube Research & Technologies (QRT)
51
Qube Research & Technologies (QRT)
United Kingdom
– -$29K -964 Closed
SSA
52
Schonfeld Strategic Advisors
New York
– -$29K -960 Closed
CSS
53
Cubist Systematic Strategies
Connecticut
– -$15K -511 Closed
Dimensional Fund Advisors
54
Dimensional Fund Advisors
Texas
– -$15K -504 Closed
CUAMC
55
China Universal Asset Management Company
China
– -$1K -18 Closed
1 2
3